Medicine and Dentistry
Nilotinib
100%
Reperfusion Injury
100%
Phosphotransferase
45%
Amino Terminal Sequence
45%
In Vitro
27%
Mitogen Activated Protein Kinase P38
27%
Hepatocyte
18%
Protein Tyrosine Kinase
18%
Cytokine Production
18%
Programmed Cell Death
18%
Tumor Necrosis Factor
18%
Mitogen-Activated Protein Kinase
18%
Interleukin 6
18%
Flow Cytometry
9%
Reverse Transcription Polymerase Chain Reaction
9%
Western Blot
9%
Interleukin 1
9%
Tyrosine-Kinase Inhibitor
9%
Kinase Signaling
9%
Cell Activation
9%
Chronic Myelogenous Leukemia
9%
Inflammatory Cytokine
9%
Cell Death
9%
Protein Kinase C
9%
Biochemistry, Genetics and Molecular Biology
Reperfusion
100%
Nilotinib
100%
N-Terminus
45%
Kinase
45%
Phosphotransferase
45%
P38 Mitogen-Activated Protein Kinases
27%
Hepatocyte
18%
Cytokine Production
18%
Mitogen-Activated Protein Kinase
18%
Interleukin 6
18%
Tumor Necrosis Factor
18%
Programmed Cell Death
18%
Western Blot
9%
Interleukin-1
9%
Reverse Transcription Polymerase Chain Reaction
9%
Inflammatory Cytokine
9%
Cell Activation
9%
Receptor Tyrosine Kinase Inhibitors
9%
Cell Death
9%
Receptor Tyrosine Kinase
9%
Protein Kinase C
9%
Flow Cytometry
9%
Pharmacology, Toxicology and Pharmaceutical Science
Reperfusion Injury
100%
Nilotinib
100%
Phosphotransferase
45%
Liver Ischemia
36%
Cytokine
27%
Mitogen Activated Protein Kinase P38
27%
Mitogen Activated Protein Kinase
18%
Protein Tyrosine Kinase
18%
Tumor Necrosis Factor
18%
Interleukin 6
18%
Western Blot
9%
Flow Cytometry
9%
Interleukin 1
9%
Protein Tyrosine Kinase Inhibitor
9%
Chronic Myeloid Leukemia
9%
Protein Kinase C
9%
Veterinary Science and Veterinary Medicine
Reperfusion Injury
100%
Hepatocyte
40%
Mouse
20%
Reverse Transcription Polymerase Chain Reaction
20%
Chronic Myelogenous Leukemia
20%